Navigation Links
Headache decreases appetite

Researchers have found that headache stimuli also affect the appetite centre of the brain. It is always been a mystery as to why loss of appetite often accompanies pain. People with migraine, for instance, cannot face food and it is often assumed this must be because one common linked symptom is nausea.

Scientists at Beth Israel Deaconess Medical Centre and Harvard Medical School now reveal, in a study,// the changes in the brain when pain takes away your appetite. From a group of migraine sufferers they found that their appetite decreased as headache intensified.This usually happens either before nausea or even in its absence.

Then the researchers gave pain stimuli to rats and discovered that they activated not just brain cells that transmit pain signals, but also those involved in appetite suppression. Headache stimuli lead to an acute fall in food intake during the first four hours after they are applied.This shows that there is an intimate link between the brain regions and the pain and appetite.


'"/>




Page: 1

Related medicine news :

1. Roller coasters – cause “Chronic Headache?
2. Headache splitter
3. Snoring Linked To Headaches
4. Let Anger go, Save the Headache
5. Let Anger go, Save the Headache
6. Taking Care Of Grandkids Can Give Women more than a Headache
7. Finding relief from Excruciating Headaches a challenge
8. Epilepsy Drug May Relieve Chronic Headaches
9. New Treatment For Headache
10. Epileptic Drug Found To Be Effective In Relieving Headache
11. Acupuncture May Be An Effective Treatment Against Tension-Headaches
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Headache decreases appetite

(Date:5/16/2008)...o Save Vital Services for Frail Seniors and People...wswire-USNewswire/ -- Thousands of,homecare worker...warzenegger,s proposed cuts to hours of service, w...ornia,s most vulnerable workers and the,people the...these vital,services for seniors and people with d...
(Date:5/16/2008)...sents Urban Health Institute with 10,000 Sensual O...rg at Playboy Mansion Fundraiser, LOS ANGELES, Ma...ip-hop,and R & B artist J Kwon known best for his ...ll be presenting the Urban Health Institute (UHI) ... over $50,000. The donation is,being made to promo...
(Date:5/16/2008)...docs determine who would benefit most from chemo a... 16 (HealthDay News) -- A panel of 15 genes may he...mall cell lung cancer will experience a recurrence...y, a new study shows. , By extension, the same... less aggressive forms of the cancer who would be ...
(Date:5/16/2008)...TON, May 16 /PRNewswire-USNewswire/ -- As tropical...e Irrawaddy delta, survivors of,Cyclone Nargis are... Many,survivors still need assistance, as exposure... an increasingly dire situation., "The people liv...,recover from this disaster and get back on their ...
Breaking Medicine News(10 mins):Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2Health News:Everybody in the Club Scream O! 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Myanmar Cyclone Survivors Face New Challenges 2
...und a new cheek cell analysis which detects early ... inexpensive and early screening method for detect...cancer using buccal mucosa or cells scraped from t...rmation that separates patients with lung cancer f...
...s more likely to occur in patients who take high d...afety profile of non-steroidal anti-inflammatory d...bserved as early as three days after starting an i...ered to have one of the most favorable safety prof...
...the illnesses affecting man was generally known. I...versely affect sex life and the sperm quality in h...ntists led by Biochemist Koonakapalyam Ramasami Mu...onic alcoholism decreases the level of testosteron...
... country has strictly prohibited the import of chi...Myanmar to combat the ongoing was against Bird flu...tional border with Myanmar and there is frequently...order. Mr. C Sangnghina, The Director of State Ani...
Other Medicine News:Health News:Early Lung cancer detected by studying Cheek Cells 2
(Date:5/16/2008)...ata from three studies,evaluating associations bet...d the rate of blood transfusions, as well as the p...r erythropoiesis-stimulating agents (ESAs),in Medi...e presented at the,American Society of Clinical On... meeting will take place in Chicago from May 30 to...
(Date:5/16/2008)...ion of a Small Molecule with Dem...., May 16 /- Nektar,Therape...oday from a Phase 1,study of NKTR- 102, PEGylated ...activity in patients with refractory solid tumors....olecule PEGylation technology,produced an increase...
(Date:5/16/2008)...r Novel Approach to Blood ...wire-FirstCall/ -- Pharmacopeia (Nasdaq:,PCOP), an...el small,molecule therapeutics, announced today th...or Antagonist (DARA), showed statistically signifi... in patients with mild to,moderate hypertension. P...
(Date:5/15/2008)...- Eisai Corporation of North,America announced tod...out,compounds in the company,s oncology pipeline, ...h have been accepted for presentation at the,44th ... Oncology (ASCO),taking place in Chicago from May... on Eisai marketed products and,investigational co...
Breaking Medicine Technology:New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 3New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 4New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 5New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 6Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8Hospital Launches Landmark Project in Emergency Medicine 9268 1Hospital Launches Landmark Project in Emergency Medicine 9268 2Hanger Orthopedic Group Inc Announces 2007 Year End Earnings Release Conference Call 9265 1Hanger Orthopedic Group Inc Announces 2007 Year End Earnings Release Conference Call 9265 2International Association of Fire Fighters 28IAFF 29 Advocates Screening Fire Fighters for Carbon Monoxide Poisoning Using Pulse CO Oximetry 2508 1International Association of Fire Fighters 28IAFF 29 Advocates Screening Fire Fighters for Carbon Monoxide Poisoning Using Pulse CO Oximetry 2508 2International Association of Fire Fighters 28IAFF 29 Advocates Screening Fire Fighters for Carbon Monoxide Poisoning Using Pulse CO Oximetry 2508 3International Association of Fire Fighters 28IAFF 29 Advocates Screening Fire Fighters for Carbon Monoxide Poisoning Using Pulse CO Oximetry 2508 4International Association of Fire Fighters 28IAFF 29 Advocates Screening Fire Fighters for Carbon Monoxide Poisoning Using Pulse CO Oximetry 2508 5Other highlights in the Jan 8 JNCI 9262 1Other highlights in the Jan 8 JNCI 9262 2Other highlights in the Jan 8 JNCI 9262 3Other highlights in the Jan 8 JNCI 9262 4
...- CombinatoRx,Incorporated (NASDAQ: CRXX) today a...ed to its immuno-inflammatory product,candidates, ...t,Rheumatism (EULAR) Annual Congress of Rheumatolo... CRx-102 , In a poster entitled "Inhibition of Mac...CRx-102, a Novel Synergistic Combination,Drug Cand...
...bjective Sleep,Measures, MINNEAPOLIS, June 13, 200...ults presented today at SLEEP 2007, the 21st annua...ieties (APSS),VEC-162, a balanced melatonin (MT1/...rmaceuticals Inc. , demonstrated improvements,in o...d maintenance,in a Phase III trial of transient in...
Other Medicine Technology:Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 2Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 3Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 4Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and,Maintenance vs. Placebo 2Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and,Maintenance vs. Placebo 3Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and,Maintenance vs. Placebo 4
Pre-Loaded with a Stylet., ,Available Cuffed or Uncuffed, pre-loaded with a stylet to facilitate quick intubations.
Worlds 1st spray on medical gel lubricant, Sprayglyde was specifically designed to assist the insertion of laryngeal masks.
Pediatric Tracheal Tubes with Micro-thin-walled cuffs.
Indications For Usage: , Emergency use. , When medicant during ventilation is required.
Medicine Products: